Mechanisms of Akt-dependent sensitivity to rapamycin
Mechanisms of Akt-dependent sensitivity to rapamycin
批准号:
7877802
负责人:
JOSEPH F GERA
金额:
$20.47万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-15 至 2013-05-31
关键词:
AddressAffectBindingBiological AssayCCI-779Cell CycleCell Cycle ArrestCell Cycle ProgressionCell NucleusCell modelCell physiologyCellsCellular StressClinicalClinical ResearchCollaborationsCombined Modality TherapyComplexCyclin D1CytoplasmDataDevelopmentDown-RegulationEventG1 ArrestGenesGlioblastomaGliomaGoalsGrowth FactorHumanHypersensitivityIn VitroInternal Ribosome Entry SiteLaboratoriesLeadLinkMAP Kinase GeneMAPK14 geneMaintenanceMalignant NeoplasmsMediatingMedicineMitogen-Activated Protein Kinase InhibitorMolecular ConformationNuclearNutrientPTEN genePathologyPathway interactionsPatientsPhosphorylationPhosphotransferasesPrimary NeoplasmProtein BindingProtein BiosynthesisProteinsProto-Oncogene Proteins c-mycRNA annealingRNA-Binding ProteinsRegulationReportingResearchResistanceRibosomesRoleSamplingSerineSignal TransductionSirolimusSiteSpecimenStructureTestingTherapeutic AgentsTissuesTranscriptTranslatingTranslation InitiationTranslationsTransport ProcessUntranslated RegionsXenograft Modelantitumor agentc-myc Genesdesignfallsfollow-upglioma cell linehnRNP A1human FRAP1 proteinin vivoin vivo Modelinhibitor/antagonistinsightmRNA StabilitymTOR InhibitormTOR inhibitionneoplastic cellnovelnovel therapeuticspre-clinicalpreventprotein expressionpublic health relevanceresearch clinical testingresearch studyresponsetraffickingtranslation factortumortumor growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long range goal of the proposal is to investigate the mechanism of cap-independent translation of the c- myc protein with the assumption that its cellular function is a key determinant of tumor cell responses, especially for CNS malignancies. More specifically, the proposal will elucidate how hnRNP A1 (A1) functions as a trans-acting protein that binds to the internal ribosome entry site (IRES) in the 5' UTR of the c-myc transcript, thus facilitating IRES-dependent translation of myc. Furthermore, it will focus on the ability of Akt and MAPK cascades to regulate this A1 translation-promoting activity, testing effects on the IRES-annealing activity of A1, effects on IRES-ribosome binding and effects on A1/IRES subcellular localization. Glioma cell lines, primary tumor cells and xenograft models will be used to exploit the insight gained on A1/myc IRES regulatory controls to understand mechanisms of glioma cell resistance whe treatment with mTOR inhibitors is attempted. PUBLIC HEALTH RELEVANCE: The project details the mechanisms by which glioma tumor cells become resistant to promising new therapeutic agents called mTOR inhibitors. The mechanisms of cell intrinsic resistance to these compounds will be investigated, as well as, the pre-clinical evaluation of combination targeted therapies in glioma in vitro and in vivo models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Co-targeting mTOR and YAP signaling in glioblastoma
-
批准号:9889911
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2018
-
负责人:JOSEPH F GERA
-
依托单位:
Co-targeting mTOR and YAP signaling in glioblastoma
-
批准号:10382229
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2018
-
负责人:JOSEPH F GERA
-
依托单位:
Mechanisms of Resistance to mTOR-Targeted Therapies
-
批准号:9339574
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:JOSEPH F GERA
-
依托单位:
Mechanisms of Resistance to mTOR-Targeted Therapies
-
批准号:8907659
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:JOSEPH F GERA
-
依托单位:
Mechanisms of Resistance to mTOR-Targeted Therapies
-
批准号:8735575
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:JOSEPH F GERA
-
依托单位:
Mechanisms of Resistance to mTOR Targeted Therapies
-
批准号:10266024
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:JOSEPH F GERA
-
依托单位:
Mechanisms of Resistance to mTOR-Targeted Therapies
-
批准号:8974387
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:JOSEPH F GERA
-
依托单位:
Mechanisms of Resistance to mTOR Targeted Therapies
-
批准号:10579603
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:JOSEPH F GERA
-
依托单位:
Dysregulation of mTORC2 in gliomas
-
批准号:8341292
-
项目类别:
-
资助金额:$22.97万
-
财政年份:2012
-
负责人:JOSEPH F GERA
-
依托单位:
Dysregulation of mTORC2 in gliomas
-
批准号:8658059
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2012
-
负责人:JOSEPH F GERA
-
依托单位:
Dysregulation of mTORC2 in gliomas
-
批准号:8512676
-
项目类别:
-
资助金额:$21.59万
-
财政年份:2012
-
负责人:JOSEPH F GERA
-
依托单位:
Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo
-
批准号:7727057
-
项目类别:
-
资助金额:$27.58万
-
财政年份:2008
-
负责人:JOSEPH F GERA
-
依托单位:
Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo
-
批准号:8088200
-
项目类别:
-
资助金额:$26.5万
-
财政年份:2008
-
负责人:JOSEPH F GERA
-
依托单位:
Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo
-
批准号:8257976
-
项目类别:
-
资助金额:$26.5万
-
财政年份:2008
-
负责人:JOSEPH F GERA
-
依托单位:
Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo
-
批准号:7883554
-
项目类别:
-
资助金额:$27.32万
-
财政年份:2008
-
负责人:JOSEPH F GERA
-
依托单位:
Regulation of c-myc translation by hnRNP A1: role in multiple myeloma tumor respo
-
批准号:8509516
-
项目类别:
-
资助金额:$24.91万
-
财政年份:2008
-
负责人:JOSEPH F GERA
-
依托单位:
Mechanisms of Akt-dependent sensitivity to rapamycin
-
批准号:8266269
-
项目类别:
-
资助金额:$19.85万
-
财政年份:2005
-
负责人:JOSEPH F GERA
-
依托单位:
Mechanisms of AKT-dependent sensitivity to rapamycin
-
批准号:7409068
-
项目类别:
-
资助金额:$19.49万
-
财政年份:2005
-
负责人:JOSEPH F GERA
-
依托单位:
Mechanisms of AKT-dependent sensitivity to rapamycin
-
批准号:7095977
-
项目类别:
-
资助金额:$20.07万
-
财政年份:2005
-
负责人:JOSEPH F GERA
-
依托单位:
Mechanisms of AKT-dependent sensitivity to rapamycin
-
批准号:7230526
-
项目类别:
-
资助金额:$19.49万
-
财政年份:2005
-
负责人:JOSEPH F GERA
-
依托单位:
海外基金